Login / Signup

Addition of adjuvant hepatic artery infusion to systemic chemotherapy following resection of colorectal liver metastases is associated with reduced liver-related mortality.

Rami M SroujiRaja NarayanThomas BoernerFlorian BuismanKen SeierMithat GonenVinod P BalachandranJeffrey DrebinWilliam R JarnaginThomas Peter KinghamAlice WeiNancy E KemenyMichael I D'Angelica
Published in: Journal of surgical oncology (2020)
The addition of HAI to SYS after CRLM resection is associated with a 50% reduction in liver-related mortality at 5 years.
Keyphrases
  • liver metastases
  • cardiovascular events
  • risk factors
  • low dose
  • cardiovascular disease
  • squamous cell carcinoma
  • radiation therapy